Works matching IS 10781552 AND DT 2020 AND VI 26 AND IP 3
Results: 34
Response to: Optic neuritis induced by 5-fluorouracil chemotherapy: case report and review of the literature.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and cost.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 718, doi. 10.1177/1078155219895066
- By:
- Publication type:
- Article
Enteral tube administration of oral chemotherapy drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 703, doi. 10.1177/1078155219893449
- By:
- Publication type:
- Article
Practical considerations for the use of direct oral anticoagulants in oncology patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 692, doi. 10.1177/1078155219893008
- By:
- Publication type:
- Article
Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 768, doi. 10.1177/1078155219875797
- By:
- Publication type:
- Article
Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 680, doi. 10.1177/1078155219873014
- By:
- Publication type:
- Article
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 688, doi. 10.1177/1078155219869441
- By:
- Publication type:
- Article
Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 666, doi. 10.1177/1078155219869439
- By:
- Publication type:
- Article
Current status of eye disorders caused by docetaxel administration every 3 weeks: A case-control study in Japanese patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 655, doi. 10.1177/1078155219868761
- By:
- Publication type:
- Article
Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 647, doi. 10.1177/1078155219868758
- By:
- Publication type:
- Article
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 641, doi. 10.1177/1078155219868516
- By:
- Publication type:
- Article
Durable response after discontinuation of nivolumab therapy in the absence of disease progression or toxicity with two advanced NSCLC patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 761, doi. 10.1177/1078155219867131
- By:
- Publication type:
- Article
Nivolumab-induced lichen planus.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 758, doi. 10.1177/1078155219866248
- By:
- Publication type:
- Article
Ivosidenib induction therapy complicated by myopericarditis and cardiogenic shock: A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 754, doi. 10.1177/1078155219865934
- By:
- Publication type:
- Article
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 747, doi. 10.1177/1078155219865597
- By:
- Publication type:
- Article
Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 742, doi. 10.1177/1078155219865313
- By:
- Publication type:
- Article
Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 632, doi. 10.1177/1078155219865303
- By:
- Publication type:
- Article
Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 619, doi. 10.1177/1078155219865008
- By:
- Publication type:
- Article
Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 738, doi. 10.1177/1078155219863469
- By:
- Publication type:
- Article
Tamoxifen-induced vasculitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 735, doi. 10.1177/1078155219862342
- By:
- Publication type:
- Article
Immunotherapy-induced severe neutropenia with neurotoxicity: A case of a 75-year-old woman with ulcerative colitis diagnosed with melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 730, doi. 10.1177/1078155219862341
- By:
- Publication type:
- Article
Comparison between two premedication regimens of dexamethasone before a pemetrexed-based chemotherapy: A single-center experience study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 612, doi. 10.1177/1078155219862040
- By:
- Publication type:
- Article
Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 603, doi. 10.1177/1078155219862035
- By:
- Publication type:
- Article
Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 595, doi. 10.1177/1078155219861679
- By:
- Publication type:
- Article
Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 587, doi. 10.1177/1078155219861423
- By:
- Publication type:
- Article
The role of antimicrobial prophylaxis in patients with head and neck cancer undergoing chemoradiation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 580, doi. 10.1177/1078155219859614
- By:
- Publication type:
- Article
Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 572, doi. 10.1177/1078155219857800
- By:
- Publication type:
- Article
Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 564, doi. 10.1177/1078155219855127
- By:
- Publication type:
- Article
Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma – A retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 556, doi. 10.1177/1078155219854797
- By:
- Publication type:
- Article
Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 549, doi. 10.1177/1078155219852412
- By:
- Publication type:
- Article
Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk–Zaske method or Bayesian method.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 543, doi. 10.1177/1078155219851834
- By:
- Publication type:
- Article
Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician–pharmacist clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 536, doi. 10.1177/1078155219851550
- By:
- Publication type:
- Article
Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 529, doi. 10.1177/1078155219851543
- By:
- Publication type:
- Article
Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measures.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 521, doi. 10.1177/1078155219850298
- By:
- Publication type:
- Article